In this issue of JAMA Surgery, LeMaire et al1 present their findings from a set of experiments performed in a standard animal model of aortic aneurysm and dissection (AAD) that convincingly demonstrates that the addition of ciprofloxacin to a challenge-induced model of AAD is associated with severe aortic destruction, increased incidence of aortic aneurysm, dissection, and death. Importantly, this occurs in multiple different aortic segments (most commonly in the ascending aorta) and in both sexes. The authors then decipher the likely multiple mechanisms by which this occurs in their in vivo model, as well as in experiments using in vitro treatment of aortic smooth muscle cells.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Upchurch GR. Evidence Against the Use of Fluoroquinolones in Patients With Aortic Pathology. JAMA Surg. 2018;153(9):e181988. doi:10.1001/jamasurg.2018.1988
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: